Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079883 · ClinicalTrials.gov registry record
Ocriplasmin Research to Better Inform Treatment (ORBIT)
A clinical trial, sponsored by ThromboGenics.
- Completed
- Registry status
- 540
- Enrollment target
NCT02079883 is a clinical trial that has completed, run by ThromboGenics. The registered enrollment target is 540 participants.
The verdict
NCT02079883 has completed, sponsored by ThromboGenics.
- COMPLETED
- Registry status
- 540 participants
- Enrollment target
Study Summary
This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes in 1500 patients recruited across approximately 120 USA retina sites.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02079883
The ClinicalTrials.gov registry entry for NCT02079883 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ThromboGenics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02079883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02079883 about?
NCT02079883 is a clinical study titled "Ocriplasmin Research to Better Inform Treatment (ORBIT)". This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes in 1500 patients recruited acro...
What is the current status of trial NCT02079883?
This trial is currently completed. The enrollment target is 540 participants. The study started on 2014-05. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT02079883?
This trial is sponsored by ThromboGenics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.